Crossref
Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy
Yearbook of Paediatric Endocrinology · 30.09.2025
DOI: 10.1530/ey.22.12.13 ↗Kurz gefasst
Fachartikel in der Zeitschrift Yearbook of Paediatric Endocrinology, online erschienen am 30.09.2025. Verfasst von Gaudet D und 20 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
D, G., S, G., LF, R., G, I., RS, R., S, S., C, S., E, S., A, W., T, T., S, A., P, B., T, D., J, M., A, W., RT, G., XQ, Z., R, P., J, Z., …, & FJ, R. (2025). Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy. Yearbook of Paediatric Endocrinology. https://doi.org/10.1530/ey.22.12.13
Vancouver
D G, S G, LF R, G I, RS R, S S, et al. Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy. Yearbook of Paediatric Endocrinology. 2025. doi:10.1530/ey.22.12.13
BibTeX
@article{D2025,
author = {D, Gaudet and S, Greber-Platzer and LF, Reeskamp and G, Iannuzzo and RS, Rosenson and S, Saheb and C, Stefanutti and E, Stroes and A, Wiegman and T, Turner and S, Ali and P, Banerjee and T, Drewery and J, McGinniss and A, Waldron and RT, George and XQ, Zhao and R, Pordy and J, Zhao and E, Bruckert and FJ, Raal},
title = {Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy},
journal = {Yearbook of Paediatric Endocrinology},
year = {2025},
doi = {10.1530/ey.22.12.13}
}
EUVIMED